These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26856200)

  • 1. The Burden of Cardiac Rhythm Management Complications.
    Andrikopoulos GK
    Hellenic J Cardiol; 2016; 57(1):39-40. PubMed ID: 26856200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resynchronization therapy in Catalonia, Spain: Cost effectiveness of beating together or separately].
    Pastor P; Zamorano JL
    Med Clin (Barc); 2016 May; 146(10):440-2. PubMed ID: 27133910
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac Arrhythmias in Adults with Congenital Heart Disease: Pacemakers, Implantable Cardiac Defibrillators, and Cardiac Resynchronization Therapy Devices.
    Cecchin F; Halpern DG
    Card Electrophysiol Clin; 2017 Jun; 9(2):319-328. PubMed ID: 28457245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.
    Groeneveld PW; Dixit S
    Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario.
    Boriani G; Burri H; Mantovani LG; Maniadakis N; Leyva F; Kautzner J; Lubinski A; Braunschweig F; Jung W; Lozano IF; Fattore G
    Europace; 2011 May; 13 Suppl 2():ii59-65. PubMed ID: 21518752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 9. A migrant left ventricular lead.
    Malagù M; Marcantoni L; Scalone A; Toselli T; Pratola C; Bertini M
    J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):782-783. PubMed ID: 25068277
    [No Abstract]   [Full Text] [Related]  

  • 10. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated guidelines for device-based therapy of cardiac rhythm abnormalities.
    Gillinov AM
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1285. PubMed ID: 23140961
    [No Abstract]   [Full Text] [Related]  

  • 12. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Tracy CM; Epstein AE; Darbar D; Dimarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD
    J Am Coll Cardiol; 2012 Oct; 60(14):1297-313. PubMed ID: 22975230
    [No Abstract]   [Full Text] [Related]  

  • 14. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Tracy CM; Epstein AE; Darbar D; Dimarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD
    Heart Rhythm; 2012 Oct; 9(10):1737-53. PubMed ID: 22975672
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantable devices currently used in cardiology therapy.
    Taylor J
    Eur Heart J; 2010 Oct; 31(20):2436-8. PubMed ID: 20947528
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey.
    Chen J; Hocini M; Larsen TB; Proclemer A; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2015 Feb; 17(2):314-7. PubMed ID: 25634939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy.
    Roubicek T; Wichterle D; Kucera P; Nedbal P; Kupec J; Sedlakova J; Cerny J; Stros J; Kautzner J; Polasek R
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1113-21. PubMed ID: 26338831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    ; Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; ; Epstein AE; DiMarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; ; Anderson JL; Jacobs AK; Halperin JL; Albert NM; Creager MA; DeMets D; Ettinger SM; Guyton RA; Hochman JS; Kushner FG; Ohman EM; Stevenson W; Yancy CW; ; ; ; ;
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):e127-45. PubMed ID: 23140976
    [No Abstract]   [Full Text] [Related]  

  • 20. Left univentricular pacing for cardiac resynchronization therapy.
    Burri H; Prinzen FW; Gasparini M; Leclercq C
    Europace; 2017 Jun; 19(6):912-919. PubMed ID: 28339579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.